GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Construction In Progress

Korea Pharma Co (XKRX:032300) Construction In Progress : ₩2,209 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Construction In Progress?

Korea Pharma Co's quarterly construction in progress increased from Sep. 2024 (₩1,316 Mil) to Dec. 2024 (₩2,354 Mil) but then declined from Dec. 2024 (₩2,354 Mil) to Mar. 2025 (₩2,209 Mil).

Korea Pharma Co's annual construction in progress declined from Dec. 2022 (₩2,039 Mil) to Dec. 2023 (₩952 Mil) but then increased from Dec. 2023 (₩952 Mil) to Dec. 2024 (₩2,354 Mil).


Korea Pharma Co Construction In Progress Historical Data

The historical data trend for Korea Pharma Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Construction In Progress Chart

Korea Pharma Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only 945.48 998.96 2,038.69 952.42 2,353.98

Korea Pharma Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 966.38 1,257.83 1,316.43 2,353.98 2,209.38

Korea Pharma Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Korea Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR
Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co Headlines

No Headlines